Northside Hospital, Inc. - GCS/Northside is a clinical research site located in Atlanta, Georgia, United States 30342.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Northside Hospital, Inc. - GCS/Northside has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Georgia · View every site in Atlanta
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northside Hospital, Inc. - GCS/Northside has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northside Hospital, Inc. - GCS/Northside has 4 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.
Northside Hospital, Inc. - GCS/Northside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.